Alzheimer Disease Clinical Trials in Cambridge
4 recruitingCambridge, United Kingdom
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled140 locationsNCT07011745
Recruiting
Trial-Ready Cohort-Down Syndrome (TRC-DS)
DementiaAlzheimer DiseaseDown Syndrome
University of Southern California450 enrolled20 locationsNCT04165109
Recruiting
Optical Neuroimaging and Cognition
Alzheimer DiseaseDementia With Lewy BodiesMild Cognitive Impairment
University of Cambridge200 enrolled1 locationNCT05460143